vs
STANDARD BIOTOOLS INC.（LAB）与Local Bounti Corporation（LOCL）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Local Bounti Corporation的1.6倍（$19.6M vs $12.5M），Local Bounti Corporation净利率更高（-69.8% vs -177.4%，领先107.6%），Local Bounti Corporation同比增速更快（23.7% vs -11.5%），Local Bounti Corporation自由现金流更多（$-3.6M vs $-23.1M），过去两年Local Bounti Corporation的营收复合增速更高（21.9% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Local Bounti是总部位于美国的可持续室内农业企业，采用水培和垂直农业技术种植无农药绿叶蔬菜、香草等生鲜农产品，主要服务北美零售连锁超市及餐饮客户，主打低环境影响、短供应链的全年稳定供货。
LAB vs LOCL — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $12.5M |
| 净利润 | $-34.7M | $-8.7M |
| 毛利率 | 48.5% | 12.2% |
| 营业利润率 | -168.5% | -106.1% |
| 净利率 | -177.4% | -69.8% |
| 营收同比 | -11.5% | 23.7% |
| 净利润同比 | -28.8% | 76.0% |
| 每股收益（稀释后） | $-0.09 | $1.52 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $12.5M | ||
| Q3 25 | $19.6M | $12.2M | ||
| Q2 25 | $21.8M | $12.1M | ||
| Q1 25 | $40.8M | $11.6M | ||
| Q4 24 | — | $10.1M | ||
| Q3 24 | $22.1M | $10.2M | ||
| Q2 24 | $22.5M | $9.4M | ||
| Q1 24 | $45.5M | $8.4M |
| Q4 25 | — | $-8.7M | ||
| Q3 25 | $-34.7M | $-26.4M | ||
| Q2 25 | $-33.5M | $-21.6M | ||
| Q1 25 | $-26.0M | $-37.7M | ||
| Q4 24 | — | $-36.3M | ||
| Q3 24 | $-26.9M | $-34.3M | ||
| Q2 24 | $-45.7M | $-25.3M | ||
| Q1 24 | $-32.2M | $-24.1M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | 48.5% | 11.5% | ||
| Q2 25 | 48.8% | 12.2% | ||
| Q1 25 | 48.4% | 12.6% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | 54.9% | 13.8% | ||
| Q2 24 | 46.1% | 14.3% | ||
| Q1 24 | 53.1% | 9.4% |
| Q4 25 | — | -106.1% | ||
| Q3 25 | -168.5% | -149.4% | ||
| Q2 25 | -118.1% | -127.7% | ||
| Q1 25 | -80.8% | -135.6% | ||
| Q4 24 | — | -166.6% | ||
| Q3 24 | -120.9% | -176.0% | ||
| Q2 24 | -134.5% | -146.8% | ||
| Q1 24 | -132.2% | -122.9% |
| Q4 25 | — | -69.8% | ||
| Q3 25 | -177.4% | -216.6% | ||
| Q2 25 | -153.7% | -178.3% | ||
| Q1 25 | -63.8% | -324.6% | ||
| Q4 24 | — | -360.1% | ||
| Q3 24 | -122.0% | -335.2% | ||
| Q2 24 | -203.3% | -267.6% | ||
| Q1 24 | -70.6% | -286.9% |
| Q4 25 | — | $1.52 | ||
| Q3 25 | $-0.09 | $-1.18 | ||
| Q2 25 | $-0.09 | $-1.63 | ||
| Q1 25 | $-0.07 | $-4.32 | ||
| Q4 24 | — | $-4.24 | ||
| Q3 24 | $-0.07 | $-4.01 | ||
| Q2 24 | $-0.12 | $-3.00 | ||
| Q1 24 | $-0.27 | $-2.89 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $4.2M |
| 总债务越低越好 | — | $483.1M |
| 股东权益账面价值 | $399.7M | $-166.2M |
| 总资产 | $539.6M | $410.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $4.2M | ||
| Q3 25 | $129.4M | $6.2M | ||
| Q2 25 | $158.6M | $5.3M | ||
| Q1 25 | $150.9M | $18.0M | ||
| Q4 24 | — | $937.0K | ||
| Q3 24 | $210.6M | $317.0K | ||
| Q2 24 | $269.8M | $9.7M | ||
| Q1 24 | $287.1M | $8.2M |
| Q4 25 | — | $483.1M | ||
| Q3 25 | — | $484.9M | ||
| Q2 25 | — | $478.3M | ||
| Q1 25 | — | $480.0M | ||
| Q4 24 | — | $436.8M | ||
| Q3 24 | $55.2M | $398.4M | ||
| Q2 24 | $55.1M | $374.0M | ||
| Q1 24 | $55.0M | $329.8M |
| Q4 25 | — | $-166.2M | ||
| Q3 25 | $399.7M | $-158.1M | ||
| Q2 25 | $424.5M | $-132.7M | ||
| Q1 25 | $454.6M | $-134.5M | ||
| Q4 24 | — | $-100.5M | ||
| Q3 24 | $489.3M | $-65.6M | ||
| Q2 24 | $510.3M | $-32.8M | ||
| Q1 24 | $577.3M | $-9.4M |
| Q4 25 | — | $410.5M | ||
| Q3 25 | $539.6M | $417.8M | ||
| Q2 25 | $557.0M | $426.8M | ||
| Q1 25 | $579.6M | $447.2M | ||
| Q4 24 | — | $428.0M | ||
| Q3 24 | $681.5M | $430.8M | ||
| Q2 24 | $708.7M | $438.1M | ||
| Q1 24 | $777.7M | $413.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-3.1M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-3.6M |
| 自由现金流率自由现金流/营收 | -118.1% | -29.1% |
| 资本支出强度资本支出/营收 | 4.5% | 3.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $-42.9M |
8季度趋势，按日历期对齐
| Q4 25 | — | $-3.1M | ||
| Q3 25 | $-22.2M | $-8.9M | ||
| Q2 25 | $-20.7M | $-8.7M | ||
| Q1 25 | $-30.3M | $-9.6M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | $-27.9M | $-17.2M | ||
| Q2 24 | $-39.0M | $-4.0M | ||
| Q1 24 | $-62.5M | $-7.1M |
| Q4 25 | — | $-3.6M | ||
| Q3 25 | $-23.1M | $-10.1M | ||
| Q2 25 | $-22.6M | $-14.6M | ||
| Q1 25 | $-35.3M | $-14.5M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | $-30.1M | $-30.0M | ||
| Q2 24 | $-41.0M | $-28.8M | ||
| Q1 24 | $-63.3M | $-42.1M |
| Q4 25 | — | -29.1% | ||
| Q3 25 | -118.1% | -82.8% | ||
| Q2 25 | -103.6% | -121.0% | ||
| Q1 25 | -86.6% | -125.1% | ||
| Q4 24 | — | -85.3% | ||
| Q3 24 | -136.4% | -293.1% | ||
| Q2 24 | -182.2% | -305.4% | ||
| Q1 24 | -138.9% | -501.8% |
| Q4 25 | — | 3.9% | ||
| Q3 25 | 4.5% | 9.7% | ||
| Q2 25 | 8.7% | 48.9% | ||
| Q1 25 | 12.4% | 42.8% | ||
| Q4 24 | — | 97.6% | ||
| Q3 24 | 10.2% | 125.0% | ||
| Q2 24 | 8.6% | 263.0% | ||
| Q1 24 | 1.7% | 417.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
LOCL
暂无分部数据
